Andrew G. Polson

ScholarGPS® ID: 57188678784295

Affiliation

Genentech, Inc., South San Francisco, United States

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

Predicted Citations

3,738

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomas (journal article) Schuster, Stephen J. \| Huw, Ling-Yuh \| Bolen, Christopher R. \| Maximov, Victor \| Polson, Andrew G. \| Hatzi, Katerina \| Lasater, Elisabeth A. \| Assouline, Sarit E. \| Bartlett, Nancy L. \| Budde, L. Elizabeth \| ... \| Penuel, Elicia Blood, volume 143, issue 9, pages 822-832 (2024). 10.1182/blood.2023022348 Cited by (7) \| Cite \| Source
T cell–Dependent Bispecific Therapy Enhances Innate Immune Activation and Antibody-Mediated Killing (journal article) Besla, Rickvinder \| Penuel, Elicia \| Del Rosario, Geoff \| Cosino, Ely \| Myrta, Szymon \| Dillon, Mike \| Lazar, Greg A. \| Nickles, Dorothee \| Spiess, Christoph \| Yu, Shang-Fan \| Polson, Andrew G. Cancer Immunology Research, volume 12, issue 1, pages 60-71 (2024). 10.1158/2326-6066.CIR-23-0072 Cited by (1) \| Cite \| Source
Novel CD20 Mutations As a Mechanism of Resistance to CD20-CD3 Targeted Therapies in Non-Hodgkin's Lymphoma (journal article) Maximov, Victor \| Bolen, Christopher R. \| Polson, Andrew G. \| Penuel, Elicia \| Lasater, Elisabeth A. Blood, volume 142, issue Supplement 1, pages 2808-2808 (2023). 10.1182/blood-2023-187696 Cited by (1) \| Cite \| Source
Development of T-cell engagers selective for cells co-expressing two antigens (journal article) Dicara, Danielle M. \| Bhakta, Sunil \| Go, Mary Ann \| Ziai, James \| Firestein, Ron \| Forrest, Bill \| Gu, Chen \| Leong, Steven R. \| Lee, Genee \| Yu, Shang-Fan \| ... \| Agard, Nicholas J. mAbs, volume 14, issue 1 (2022). 10.1080/19420862.2022.2115213 Cited by (8) \| Cite \| Source
Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study (journal article) Herrera, Alex F. \| Patel, Manish R. \| Burke, John M. \| Advani, Ranjana \| Cheson, Bruce D. \| Sharman, Jeff P. \| Penuel, Elicia \| Polson, Andrew G. \| Liao, Chen Di \| Li, Chunze \| ... \| Diefenbach, Catherine Clinical Cancer Research, volume 28, issue 7, pages 1294-1301 (2022). 10.1158/1078-0432.CCR-21-3261 Cited by (15) \| Cite \| Source
Calicheamicin Antibody–Drug Conjugates with Improved Properties (journal article) Vollmar, Breanna S. \| Frantz, Chris \| Schutten, Melissa M. \| Zhong, Fiona \| del Rosario, Geoffrey \| Go, Mary Ann T. \| Yu, Shang-Fan \| Leipold, Douglas D. \| Kamath, Amrita V. \| Ng, Carl \| ... \| Pillow, Thomas H. Molecular Cancer Therapeutics, volume 20, issue 6, pages 1112-1120 (2021). 10.1158/1535-7163.MCT-20-0035 Cited by (17) \| Cite \| Source
An Anti–CD22- seco -CBI-Dimer Antibody–Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models (journal article) Yu, Shang-Fan \| Lee, Donna W. \| Zheng, Bing \| del Rosario, Geoffrey \| Leipold, Douglas \| Booler, Helen \| Zhong, Fiona \| Carrasco-Triguero, Montserrat \| Hong, Kyu \| Yan, Peter \| ... \| Polson, Andrew G. Molecular Cancer Therapeutics, volume 20, issue 2, pages 340-346 (2021). 10.1158/1535-7163.MCT-20-0046 Cited by (9) \| Cite \| Source
Preclinical optimization of Ly6E-targeted ADCs for increased durability and efficacy of anti-tumor response (journal article) Dela Cruz Chuh, Josefa \| Go, MaryAnn \| Chen, Yvonne \| Guo, Jun \| Rafidi, Hanine \| Mandikian, Danielle \| Sun, Yonglian \| Lin, Zhonghua \| Schneider, Kellen \| Zhang, Pamela \| ... \| Agard, Nicholas J. mAbs, volume 13, issue 1 (2021). 10.1080/19420862.2020.1862452 Cited by (11) \| Cite \| Source
Silvestrol antibody-drug conjugates and methods of use (patent) Pillow, Thomas \| Polson, Andrew G. \| Zheng, Bing Patent Number: 10639378 (2020) Cite \| Source
Anti-CD33 antibodies and immunoconjugates (patent) Yu, Shang-Fan \| Liang, Wei-Ching \| Wu, Yan \| Leong, Steven \| Polson, Andrew Patent Number: 10556951 (2020) Cite \| Source
Anti-CD79B antibodies and immunoconjugates and methods of use (patent) Chen, Yvonne \| Dennis, Mark \| Dornan, David \| Elkins, Kristi \| Junutula, Jagath Reddy \| Polson, Andrew \| Zheng, Bing Patent Number: 10544218 (2020) Cite \| Source
Anti-CLL-1 antibodies and methods of use (patent) Kelley, Robert F. \| Leong, Steven R. \| Liang, Wei-Ching \| Mathieu, Mary \| Polson, Andrew G. \| Zheng, Bing \| Chen, Xiaocheng \| Chiu, Cecilia Pui Chi \| Dennis, Mark S. \| Ebens, Allen \| Wu, Yan Patent Number: 10501545 (2019) Cite \| Source
Anti-CD79B antibodies and immunoconjugates and methods of use (patent) Chen, Yvonne \| Dennis, Mark \| Dornan, David \| Elkins, Kristi \| Junutula, Jagath Reddy \| Polson, Andrew \| Zheng, Bing Patent Number: 10494432 (2019) Cite \| Source
Anti-FcRH5 antibodies (patent) Ebens, Allen J. \| Hazen, Meredith C. \| Hongo, Jo-Anne \| Johnston, Jennifer W. \| Junttila, Teemu T. \| Li, Ji \| Polson, Andrew G. Patent Number: 10435471 (2019) Cite \| Source
Exposure-Efficacy Analysis of Antibody-Drug Conjugates Delivering an Excessive Level of Payload to Tissues (journal article) Zhang, Donglu \| Dragovich, Peter S. \| Yu, Shang-Fan \| Ma, Yong \| Pillow, Thomas H. \| Sadowsky, Jack D. \| Su, Dian \| Wang, Wei \| Polson, Andrew \| Khojasteh, S. Cyrus \| Hop, Cornelis E.C.A. Drug Metabolism and Disposition, volume 47, issue 10, pages 1146-1155 (2019). 10.1124/dmd.119.087023 Cited by (24) \| Cite \| Source
Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin (journal article) Li, Dongwei \| Lee, Donna \| Dere, Randall C. \| Zheng, Bing \| Yu, Shang‐Fan \| Fuh, Franklin K. \| Kozak, Katherine R. \| Chung, Shan \| Bumbaca Yadav, Daniela \| Nazzal, Denise \| ... \| Prabhu, Saileta British Journal of Pharmacology, volume 176, issue 19, pages 3805-3818 (2019). 10.1111/bph.14784 Cited by (19) \| Cite \| Source
Anti-LGR5 antibodies and uses thereof (patent) Polson, Andrew G. \| Mao, Weiguang \| Firestein, Ron Patent Number: 10316084 (2019) Cite \| Source
Anti-CLL-1 antibodies and immunoconjugates (patent) Zheng, Bing \| Polson, Andrew \| Chiu, Cecilia \| Liang, Wei-Ching \| Wu, Yan Patent Number: 10266597 (2019) Cite \| Source
Anti-CLL-1 antibodies and immunoconjugates (patent) Zheng, Bing \| Polson, Andrew \| Chiu, Cecilia \| Liang, Wei-Ching \| Wu, Yan Patent Number: 10239947 (2019) Cite \| Source
Anti-CLL-1 antibodies and immunoconjugates (patent) Zheng, Bing \| Polson, Andrew \| Chiu, Cecilia \| Liang, Wei-Ching \| Wu, Yan Patent Number: 10227412 (2019) Cite \| Source